Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David I Latoni

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Dermatologic Clinics|June 28, 2025
Systemic Therapies for Metastatic MelanomaDavid I Latoni, Soo Hyun Kim, Hensin Tsao
Journal of the American Academy of Dermatology|July 22, 2024
Differential time series analysis shows deceleration in melanoma mortality prior to the widespread use of highly effective therapiesDavid I Latoni, Yevgeniy R Semenov, Hensin Tsao
JID Innovations : Skin Science From Molecules to Population Health|September 9, 2024
Update on the Pathogenesis of Keloid FormationDavid I Latoni, Danica C McDaniel, Hensin Tsao, et al.
JAAD International|April 30, 2026
Four-week neoadjuvant 5% imiquimod prior to Mohs micrographic surgery for melanoma in situ: A prospective pilot studyDavid T Harvey, David I Latoni, Yiwen Helen Li, et al.
JAAD Case Reports|April 5, 2024
Multiple de novo spitzoid nevi arising within a specific red tattoo inkDavid I Latoni, Ruth K Foreman, Kerry Lavigne, et al.
The Journal of Investigative Dermatology|July 9, 2024
Geotemporal Analysis of Melanoma Incidence and Mortality Identifies Distinct Clusters of Trends within the United States Between 2001 and 2019David I Latoni, Alan C Geller, Yevgeniy R Semenov, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 16, 2026
Modified Needle Holder and Undermining Scissors With Integrated Rulers to Streamline Mohs ReconstructionDavid I Latoni, David T Harvey, Helen Y Li, et al.
The Journal of Clinical Investigation|January 2, 2026
Germline inactivation of tumor suppressor BAP1 is associated with white spottingChing-Ni Njauw, Zhenyu Ji, David I Latoni, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Dermatologic Clinics|June 28, 2025
Systemic Therapies for Metastatic MelanomaDavid I Latoni, Soo Hyun Kim, Hensin Tsao
Journal of the American Academy of Dermatology|July 22, 2024
Differential time series analysis shows deceleration in melanoma mortality prior to the widespread use of highly effective therapiesDavid I Latoni, Yevgeniy R Semenov, Hensin Tsao
JID Innovations : Skin Science From Molecules to Population Health|September 9, 2024
Update on the Pathogenesis of Keloid FormationDavid I Latoni, Danica C McDaniel, Hensin Tsao, et al.
JAAD International|April 30, 2026
Four-week neoadjuvant 5% imiquimod prior to Mohs micrographic surgery for melanoma in situ: A prospective pilot studyDavid T Harvey, David I Latoni, Yiwen Helen Li, et al.
JAAD Case Reports|April 5, 2024
Multiple de novo spitzoid nevi arising within a specific red tattoo inkDavid I Latoni, Ruth K Foreman, Kerry Lavigne, et al.
The Journal of Investigative Dermatology|July 9, 2024
Geotemporal Analysis of Melanoma Incidence and Mortality Identifies Distinct Clusters of Trends within the United States Between 2001 and 2019David I Latoni, Alan C Geller, Yevgeniy R Semenov, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 16, 2026
Modified Needle Holder and Undermining Scissors With Integrated Rulers to Streamline Mohs ReconstructionDavid I Latoni, David T Harvey, Helen Y Li, et al.
The Journal of Clinical Investigation|January 2, 2026
Germline inactivation of tumor suppressor BAP1 is associated with white spottingChing-Ni Njauw, Zhenyu Ji, David I Latoni, et al.
Pageof 1